Free Trial

Y Intercept Hong Kong Ltd Has $825,000 Position in Nu Skin Enterprises, Inc. (NYSE:NUS)

Nu Skin Enterprises logo with Consumer Staples background

Y Intercept Hong Kong Ltd boosted its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 760.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,979 shares of the company's stock after purchasing an additional 98,969 shares during the period. Y Intercept Hong Kong Ltd owned 0.23% of Nu Skin Enterprises worth $825,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Pacer Advisors Inc. acquired a new position in shares of Nu Skin Enterprises during the second quarter worth approximately $25,230,000. Federated Hermes Inc. lifted its holdings in Nu Skin Enterprises by 111.8% during the 2nd quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company's stock worth $13,950,000 after buying an additional 698,722 shares in the last quarter. Jane Street Group LLC boosted its position in Nu Skin Enterprises by 358.4% in the 3rd quarter. Jane Street Group LLC now owns 924,993 shares of the company's stock valued at $6,817,000 after buying an additional 723,220 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of Nu Skin Enterprises by 5.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 901,098 shares of the company's stock valued at $9,498,000 after buying an additional 43,935 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC raised its position in shares of Nu Skin Enterprises by 27.7% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 603,555 shares of the company's stock worth $4,448,000 after acquiring an additional 130,980 shares during the last quarter. Institutional investors own 82.84% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on the company. Citigroup lowered their price objective on Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating for the company in a research report on Tuesday, October 22nd. StockNews.com upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, November 11th.

Get Our Latest Analysis on NUS

Nu Skin Enterprises Trading Down 0.4 %

Shares of NUS stock traded down $0.03 during trading hours on Friday, reaching $7.49. The company had a trading volume of 452,187 shares, compared to its average volume of 838,027. The company has a 50 day moving average of $6.91 and a 200 day moving average of $8.93. The firm has a market cap of $372.34 million, a price-to-earnings ratio of -3.62 and a beta of 1.20. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.93 and a quick ratio of 1.20. Nu Skin Enterprises, Inc. has a 1-year low of $5.95 and a 1-year high of $20.75.

Nu Skin Enterprises Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 11th. Stockholders of record on Friday, November 29th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, November 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.20%. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -11.59%.

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Articles

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Should you invest $1,000 in Nu Skin Enterprises right now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines